Paul Singer Catalent, Inc. Transaction History
Elliott Investment Management L.P.
- $16.7 Billion
- Q2 2024
A detailed history of Paul Singer (Elliott Investment Management L.P.) transactions in Catalent, Inc. stock. As of the latest transaction made, Elliott Investment Management L.P. holds 4,000,000 shares of CTLT stock, worth $242 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
4,000,000
Previous 4,000,000
-0.0%
Holding current value
$242 Million
Previous $226 Million
0.39%
% of portfolio
1.34%
Previous 1.47%
Shares
1 transactions
Others Institutions Holding CTLT
# of Institutions
489Shares Held
165MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$930 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$666 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$444 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$301 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.9B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...